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The mechanisms by which iron is absorbed are similar to those of divalent metals, particularly man-
ganese, lead, and cadmium. These metals, however, show different toxicokinetics in relation to menarche
or menopause, although their interaction with iron is the same. This review focuses on the kinetics of
these three toxic metals (manganese, lead, and cadmium) in relation to menarche, pregnancy, and
menopause. The ironemanganese interaction is the major factor determining sex-speciﬁc differences in
blood manganese levels throughout the whole life cycle. The effects of estrogen overshadow the asso-
ciation between iron deﬁciency and increased blood lead concentrations, explaining why women,
despite having lower ferritin concentrations, have lower blood lead concentrations than men. Iron
deﬁciency is associated with elevated cadmium levels in premenopausal women, but not in post-
menopausal women or men; these ﬁndings indicate that sex-speciﬁc differences in cadmium levels at
older ages are not due to ironecadmium interactions, and that further studies are required to identify the
source of these differences. In summary, the potential causes of sex-speciﬁc differences in the blood
levels of manganese, lead, and cadmium differ from each other, although all these three metals are
associated with iron deﬁciency. Therefore, other factors such as estrogen effects, or absorption rate as
well as iron deﬁciency, should be considered when addressing environmental exposure to toxic metals
and sex-speciﬁc differences in the blood levels of these metals.
 2014, Occupational Safety and Health Research Institute. Published by Elsevier. All rights reserved.1. Introduction
Toxic metals have become ubiquitous in the built environment,
and thus the general populations are increasingly becoming
exposed to these metals. Most research in toxicology and environ-
mental and occupational health has only involved men. However,
increasing evidence suggests that the toxicity of environmental
pollutants, including toxic metals, may manifest differently in
women than in men. Although many epidemiological studies have
reported data separately for men and women, differences between
the genders have seldom been evaluated [1e3]. Moreover, little is
known about toxicity in relation to speciﬁc periods inwomen’s lives,
such as menarche and menopause. Menstruation may cause iron
deﬁciency, which, in turn, may be related to increased gastrointes-
tinal absorption of toxicmetals [4,5].Mechanisms of iron absorption
are similar to those of other divalent metals, particularlyal and Environmental Medicine, U
erms of the Creative Commons At
ribution, and reproduction in any
l Safety and Health Research Institmanganese, lead, and cadmium [4,5] and a dietary deﬁciency of iron
can lead to excess absorption of manganese [6e13], lead [14e23],
and cadmium [24e29].
Metal ions showdifferent toxicokinetics in relation tomenarche,
pregnancy, or menopause, despite similar metaleiron interactions.
Thus, this review focuses on the kinetics of the toxic metals with
a similar metaleiron interaction, such as manganese, lead, and
cadmium, in relation to menarche, pregnancy, and menopause in
the general population without occupational exposure.
2. Manganese
Manganese is a naturally occurring element that is abundantly
present in the environment. It is an essential dietary nutrient
needed for proper functioning of the human body at speciﬁc con-
centrations. It plays a role in bone formation, protein and energylsan University Hospital, University of Ulsan College of Medicine, 290-3 Cheonha-
tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)
medium, provided the original work is properly cited.
ute. Published by Elsevier. All rights reserved.
Saf Health Work 2014;5:113e117114metabolism, andmetabolic regulation, and functions as a cofactor in
a number of enzymatic reactions [30]. Because manganese is an
essential element [30e32], its absorption, disposition, and biliary
excretion are actively controlled by homeostatic mechanisms
[30,33]. These processes also play an important role in manganese
toxicokinetics, which differ from those of nonessential toxic metals
such as lead and cadmium. Heavy occupational exposure to man-
ganese can cause a neurologic impairment clinically called “man-
ganism,” amotor syndrome that is similar to but differentiated from
idiopathic Parkinson’s disease [33e37]. The mechanisms involved
in iron absorption are similar to those of divalent metals, particu-
larly manganese [4,27], and a dietary deﬁciency of iron can lead to
excess absorption of manganese [6e13]. Higher concentrations of
blood manganese are reported in females of childbearing age than
in males because the former have lower concentrations of ferritin
[11,12,38]. Moreover, blood manganese levels are lower in meno-
pausal than in premenopausal women because the former have
higher concentrations of ferritin [39]. Signiﬁcant increases in the
mean whole blood manganese levels throughout the pregnancy
period were reported previously [32,40,41]. This increase in man-
ganese levels may be related to the enhanced absorption of man-
ganese due to upregulation of iron absorption, particularly during
the late pregnancy periods [42,43], because mechanisms of iron
absorption are similar to those of other divalent metals, particularly
manganese and cadmium [4,5]. However, age-related increase in
blood manganese is not observed [11], because its absorption,
disposition, and biliary excretion are actively controlled by ho-
meostaticmechanisms as an essential element [30]. Thus, the irone
manganese interaction is the major factor determining sex-speciﬁc
differences in blood manganese levels in relation to menstrual,
reproductive, and menopausal factors (Table 1) [11,32,38e41].
3. Lead
Lead is a widespread environmental pollutant that can damage
the central nervous, renal, cardiovascular, reproductive, and he-
matological systems. Lead accumulated in bones has a half-life
ranging from years (trabecular bone) to decades (cortical bone)
[44]. Approximately 90% of the lead in the body is stored in the
skeleton [45].
Because iron is absorbed bymechanisms similar to those of other
divalent metal ions, including lead and manganese, a dietary deﬁ-
ciency of iron can lead to excess absorption of lead [46e48]. Several
studies have suggested an association between iron status and
blood lead concentration in children [14e23] and in premenarchal
females [49]. However, the relationship between iron deﬁciency
and increased lead absorption has not been widely reported in
adults [50,51]. Despite having lower ferritin levels, postmenarchal
females have lower blood lead concentrations than males of similar
ages [49,52e56]. Furthermore, blood lead concentrations are higherTable 1
Behavior of blood manganese (Mn) concentrations according to age- and sex-related var
Variables Refs (n) Study populations and ﬁndings
Age [11] (2,005) Korean general population aged 20 y; KNHANES 200
Sex [11] (2,005) Korean general population aged 20 y; KNHANES 200
[38] (297) Canadian general population/GM of blood Mn in femal
Menopause [39] (1,826) Korean general population KNHANES 2008e2009/GM
1.296 mg/dL*
Pregnancy [32] (34) Australian general population/maternal blood Mn duri
[40] (290) Canadian general population/maternal blood GM ofMn
vs. 0.85 mg/dL and 0.746 mg/dL
[41] (470) Canadian general population/maternal blood AM of M
AM, arithmetic mean; GM, geometric mean; KNHANES, Korea National Health and Nutr
* Statistically signiﬁcant.in menopausal than in premenopausal women, despite the former
having higher ferritin levels. Our previous study [49] suggested that
these paradoxical ﬁndings are probably due to the potential con-
founding effect of estrogenon blood lead levels. Several studies have
shown that blood lead concentrations are higher in menopausal
than in menstruating women, because lead may be mobilized from
the skeleton during periods of increased bone demineralization,
such as in menopause [57e62]. In addition, lower blood lead levels
were observed in postmenopausal women receiving estrogen
replacement therapy than in past or never users [63e65]. The Na-
tional Health and Nutrition Examination Survey data showed that
blood lead levels were lower among girls who had attained sexual
maturity [66]. Estrogen triggers rapid bone formation during pu-
bertal development, inducing more rapid deposition of calcium, as
well as lead, from blood into bone and possibly causing redistribu-
tion of lead throughout the body. These ﬁndings indicate that the
effects of estrogen overshadow the association between iron deﬁ-
ciency and increased blood lead levels, and explain why women,
despite having lower ferritin levels, have lower blood lead levels
than men. These sex-speciﬁc differences in blood levels of lead
between men and women were reported previously [53,67]. In
addition, Wu et al [66] found a signiﬁcant difference in blood lead
concentration between Chinese male and female children aged 7e
14 years (5.072 mg/dL vs. 4.389 mg/dL), but not in children aged <7
years. Our previous report also did not show a signiﬁcant sex-spe-
ciﬁc difference in blood lead concentration between premenarchal
girls and boys [49]. Therewas also a signiﬁcant decrease in themean
whole blood lead levels throughout the pregnancy period [68e71]
although some recovery is also seen in the late stages of pregnancy
in some studies [70,72,73]. This decrease during pregnancy may be
mainly related to physiological factors, such as increases in plasma
estrogen concentrations and their effect on lead redistribution.
Thus, the decreasing effect of estrogen on blood lead is a major
determinant of sex-speciﬁc differences in blood lead levels as a
common thread relating menstrual, reproductive, and menopausal
factors (Table 2) [40,49,53,57,58,61,62,67e71,74,75]. However, age-
related increase in blood lead is observed because of increase in
exposure with age [67,74].
4. Cadmium
Cadmium is a ubiquitous environmental pollutant with a bio-
logical half-life in the body exceeding 10 years. Cadmium levels in
the body accumulatewith age, as only aminute part (0.01e0.02%) is
excreted per day [76]. Cadmium has been reported to have cumu-
lative effects onmortality and cardiovascular, neurologic, renal, and
developmental diseases [76].
Blood cadmium is a valid biomarker of recent cadmium expo-
sure [77], whereas urinary cadmium is a biomarker of lifetime
exposure to cadmium [77]. Iron and cadmium have similariables
8/No signiﬁcant change between population in the 20s and 40s
8/GM of blood Mn in females vs. males: 1.403 mg/dL vs. 1.192 mg/dL*
es vs. males: 0.750 mg/dL vs. 0.675 mg/dL*
of blood Mn in premenopausal vs. postmenopausal women: 1.443 mg/dL vs.
ng pregnancy from 10 wks to 20 wks vs. 34 wks: 0.375 mg/dL vs. 0.575 mg/dL
during pregnancy at delivery vs. 1st trimester and nonpregnant women: 1.56 mg/dL
n during pregnancy at delivery vs. nonpregnant 2.4 mg/dL vs. 0.8e1.2 mg/dL
ition Examination Survey.
Table 2
Behavior of blood lead concentrations according to age- and sex-related variables
Variables Refs (n) Study populations and ﬁndings
Age [67] (9,961) U.S. general population; NHANES 1999e2002/signiﬁcant increase with age
[74] (5,924) Korean general population aged 20 y; KNHANES 2008e2010/signiﬁcant increase with age
Sex [67] (9,961) U.S. general population; NHANES 1999e2002/GM of blood lead in men vs. women: 2.08 mg/dL vs. 1.31 mg/dL
[53] (8,793) U.S. general population; NHANES 2009e2010/GM of blood lead in men vs. women: 1.31 mg/dL vs. 0.966 mg/dL
[74] (5,924) Korean general population aged 20 y; KNHANES 2008e2010/GM of blood lead in men vs. women: 2.620 mg/dL vs. 2.008 mg/dL*
[75] (3,181) Children aged 0e14 y from Beijing, China/AM of blood lead in male children vs. female children aged 7e14 y: 5.072 mg/dL vs.
4.389 mg/dL, but no differences in children aged <7 y
[49] (798) Korean general adolescent population; KNHANES 2010e2011/GM of blood lead in premenarchal girls vs. boys: 1.403 mg/dL* vs.
1.497 mg/dL
Menarche [40] (396) Korean general adolescent population; KNHANES 2010e2011/GM of blood lead in premenarchal vs. postmenarchal girls: 1.403
mg/dL vs. 1.136 mg/dL*
Menopause [61] (745) Korean general population; KNHANES 2008e2009/blood GM of lead in premenopausal vs. postmenopausal women: 2.0 mg/dL vs.
2.274 mg/dL*
[57] (846) U.S. general population; NHANES 1976e1980/blood GM of lead in premenopausal vs. postmenopausal women aged 40e60 y:
11.63 mg/dL vs. 13.09 mg/dL*
[58] (3,136) U.S. general population; NHANES 1982e1984/blood GM of lead in premenopausal vs. postmenopausal women: 7.5 mg/dL vs. 8.9
mg/dL*
[62] (3,221) U.S. general population; NHANES 1999e2010/blood GM of lead in premenopausal vs. postmenopausal women aged 45e55 y:
1.23 mg/dL vs. 1.71 mg/dL*
Pregnancy [68] (26,570) U.S. general population; NHANES 2003e2008/blood GM of lead among pregnant women aged 18e49 y vs. nonpregnant women:
0.64 mg/dL vs. 0.85 mg/dL*
[69] (128 vs. 120) Chinese general population (Chengdu)/blood AM of 3 trimesters vs. healthy control group: 5.957 mg/dL, 5.517 mg/dL, and 5.577 mg/dL
vs. 6.87 mg/dL*
[71] (165 vs. 27) UK general population/blood AM of lead levels of pregnant vs. nonpregnant women: 12.22 mg/dL vs. 13.25 mg/dL (insigniﬁcant)
[70] (12) Australian immigrants/changes in blood GM of lead during pregnancy and postpartum followed U-shaped patterns
AM, arithmeticmean; GM, geometric mean; KNHANES, Korea National Health and Nutrition Examination Survey; NHANES, National Health and Nutrition Examination Survey.
* Statistically signiﬁcant.
B.-K. Lee and Y. Kim / Sex-speciﬁc Blood Metal Proﬁles 115absorption mechanisms [4,27], and animal experiments have
shown that metabolic interactions may take place between cad-
mium and iron [78,79]. Increased cadmium uptake in animals with
low iron stores has been documented previously [24,25,28,29].
Moreover, cadmium concentrations were shown to be associated
with decreasing iron stores in premenopausal women [1,12,52,80e
85]. Thus, blood cadmium concentrations are higher in females of
childbearing age than in males because the former have lower
ferritin concentrations [53,74,86,87]. There was a signiﬁcant in-
crease in the whole blood cadmium levels during late pregnancy, in
particular [80,88,89]. This increase in cadmium levels may be
related to enhanced cadmium absorption due to an upregulated
iron absorption, particularly during the late pregnancy period
[43,80], because mechanisms of iron absorption are similar to those
of other divalent metals, particularly manganese and cadmium
[4,5]. However, blood cadmium concentrations have rarely been
reported to decrease after menopause. Blood cadmium levels wereTable 3
Behavior of blood/urine cadmium concentrations according to age- and sex-related varia
Variables Refs (n) Study populations and ﬁndings
Age [74] (5,924) Korean general population aged 20 y; KNHANES 2008e
[53] (8,793) U.S. general population NHANES 2009e2010/GM of urin
[86] (2,257) U.S. general population aged 6 y; NHANES 2003e2004
[87] (1,055) Bangladesh general population aged 8 y/median urinar
Sex [53] (8,793) U.S. general population; NHANES 2009e2010/GM of bloo
[74] (5,924) Korean general population aged 20 y; KNHANES 2008e
[86] (2,257) U.S. general population aged 6 y; NHANES 2003e2004
difference in children aged 6e11 y
[87] (1,055) Bangladesh general population aged8 y/median urinary
0.88 mg/L vs. 1.1 mg/L
Menopause [93] (3,700) Korean general population/blood GM of cadmium in pre
[87] (149) Bangladesh general population aged >51 y/median urina
[91] (1,670) German general population aged 25 y/between-gender
<50 y
Pregnancy [97] (120) Spanish general population/no signiﬁcant changes in uri
[88] (2,882) Chinese general population/signiﬁcant changes in the blo
women; 0.75 mg/L vs. 0.5 mg/L
[89] (281) Bangladesh general population/median blood cadmium i
[80] (216) Swedish general population/median blood cadmium incr
GM, geometric mean; KNHANES, Korea National Health and Nutrition Examination Surv
* Statistically signiﬁcant.found to be higher in menopausal than in premenopausal women,
and higher in postmenopausal women than in men of corre-
sponding age. By contrast, one study found no statistically signiﬁ-
cant differences in blood cadmium levels in postmenopausal and
premenopausal women [90]; however, urinary cadmium concen-
trations were higher inwomen than inmen aged over 50 years [87],
with between-gender differences greater in individuals aged >50
years than those aged <50 years [91]. In addition, cadmium levels
were signiﬁcantly higher in the hair of elderly females than males
[92]. Similarly, our recent study [93] found that blood cadmium
concentrations were higher inwomen than in men aged>50 years,
and there was no association between iron deﬁciency and elevated
cadmium levels in postmenopausal women [94,95] or in men
[85,96]. Thus, sex-speciﬁc differences in cadmium levels at older
ages are not only due to ironecadmium interaction, but also due to
a higher absorption rate in females than in males that could be also
inﬂuenced by other confounding factors (iron stores; Table 3)bles
2010/GM of blood cadmium had a signiﬁcant increase with age
ary cadmium had a signiﬁcant increase with age
/GM of urinary cadmium had a signiﬁcant increase with age
y cadmium levels had a signiﬁcant increase with age
d cadmium in men vs. women: 0.279 mg/L vs. 0.326 mg/L*
2010/GM of blood cadmium in men vs. women: 0.780 mg/L vs. 1.194 mg/L*
/GM of urinary cadmium in men aged 12 y was lower than in women; but no
cadmium level in men aged 30e50 y, 51e88 y vs. women; 0.66 mg/L vs. 0.81 mg/L,
menopausal vs. postmenopausal women: 0.995 mg/L vs. 1.165 mg/L*
ry cadmium in women vs. men: 1.1 mg/L vs. 0.88 mg/L
differences in blood GM of cadmium greater in individuals aged >50 y than aged
nary GM of cadmium during pregnancy and postpartum: 0.44 mg/L vs. 0.64 mg/L
od median cadmium between during late pregnancy periods and nonpregnant
ncreased 15% from early pregnancy (0.5 mg/L) to 6 mo postpartum
eased 13% from early pregnancy (0.16 mg/L) to 3 mo postpartum
ey; NHANES, National Health and Nutrition Examination Survey.
Saf Health Work 2014;5:113e117116[53,74,80,86e89,91,93,97,98]. Further study is required to clarify
the source of these differences. However, age-related increase in
blood cadmium is remarkable because of increase in oral exposure
with age [53,74,86].
5. Summary
Exposure is the major determinant of blood/urine metal con-
centrations in humans. This review focused on the general popu-
lation without occupational exposure. We assumed a similar
exposure between the two sexes, which is a limitation of this re-
view, and discussed the kinetics of the toxic metals with a similar
metaleiron interaction, such as manganese, lead, and cadmium, in
relation to menstrual, reproductive, and menopausal factors.
The potential causes of sex-speciﬁc differences in the blood
levels of manganese, lead, and cadmium differ from each other,
although all three are associated with iron deﬁciency. Therefore,
other factors such as estrogen effects, or absorption rate as well as
iron deﬁciency, should be considered when addressing environ-
mental exposure to toxic metals and sex-speciﬁc differences in the
blood levels of these metals.
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